This is unpublished

Ana A.
Weil
MD, MPH

Ana A. Weil

(206) 616-0779

Center for Emerging & Re-Emerging Infectious E771

Faculty
Infectious Diseases
Pinned
Academic
Assistant Professor, Department of Medicine, Division of Allergy & Infectious Diseases

related links

Weil lab
UW department of medicine

bio

Dr. Ana Weil studies the relationship between the gut microbiome and immune responses to enteric diseases. Using molecular, genomic and immunologic methods, she investigates how the gut microbiome influences susceptibility to enteric infections, modulation of immune responses by the gut microbiome, and pathogen-gut microbe interactions at the mucosal surface.

She works with several US-based collaborators and the International Centre for Diarrhoeal Disease Research, Bangladesh.

research interests

  • microbiome science
  • immune responses to vaccination
  • host-pathogen interactions

clinical interests

  • solid organ transplant infectious diseases

education & training

MPH, Johns Hopkins University School of Public Health, Baltimore MD (2004)

MD, Tufts University School of Medicine, Medford MA (2010)

Residency, Massachusetts General Hospital, Boston MA (2013)

Fellowship, Massachusetts General Hospital, Boston MA (2015)

honors

Fulbright Scholar, Malawi (2001)

Fogarty/NIH Clinical Scholar, International Center for Diarrheal Disease Research, Bangladesh (2007)

William Damesheck Research Award, Tufts Medical School (2010)

Edward H. Kass Award for Excellence in Research, Infectious Disease Society of America (2012)

Edward H. Kass Award for Clinical Excellence, Massachusetts Infectious Disease Society (2014)

Chief Resident, Department of Medicine, Massachusetts General Hospital (2015-2016)

ID Week Abstract Committee Choice Award, ID Week Program Committee (2015)

Morton N. Swartz Professional Development Award, Division of Infectious Diseases, MGH (2018)

publications

MyNCBI

 

Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT. Estimating cholera incidence with cross-sectional serology. Science translational medicine. 2019; 11(480).
• PubMed Abstract

Ritter AS, Chowdhury F, Franke MF, Becker RL, Bhuiyan TR, Khan AI, Saha NC, Ryan ET, Calderwood SB, LaRocque RC, Harris JB, Qadri F, Weil AA. Vibriocidal Titer and Protection From Cholera in Children, Open Forum Infectious Diseases. 2019 April; 6(4):ofz057.
• PubMed Abstract

Midani FS*, Weil AA*, Chowdhury F, Begum YA, Khan AI, Debela MD, Durand HK, Reese AT, Nimmagadda SN, Silverman JD, Ellis CN, Ryan ET, Calderwood SB, Harris JB, Qadri F, David LA, LaRocque RC. Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection. The Journal of Infectious Diseases. 2018; 218(4):645-653. * Co-first authors.
• PubMed Abstract

David LA, Weil AA, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ. Gut Microbial Succession Follows Acute Secretory Diarrhea in Humans. MBio. 2015 May 19; 6(3):e00381-15.
• PubMed Abstract

Weil AA, Begum Y, Chowdhury F, Khan AI, Leung DT, LaRocque RC, Charles RC, Ryan ET, Calderwood SB, Qadri F, Harris JB. Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. Am Journal Trop Med Hyg. 2014 Oct; 91(4)738-42.
• PubMed Abstract